June 21, 2021
June 10th 2019 – Scientific publication – Brain & Development. METAglut1™ has been used as a diagnostic tool for this published research study: Dozières-Puyravel B. et […]
June 19, 2017
METAFORA is proud to announce that its first publication related to the use of its technology to diagnose a rare metabolic disease rapidly and efficientely has […]
April 12, 2016
Naomi Taylor’s research group publish new result using METAFORA’s technology: Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions. […]
April 1, 2016
Laurent Yvan-Charvet’s research team publish new result using METAFORA’s technology: Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques […]
March 15, 2016
David Finlay’s research group publish new result using METAFORA’s technology: Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells. Keating SE et al., J Immunol. 2016 […]
October 7, 2015
RBDs revealed a metabolic stress induced by statins in muscle cells. Published in Stem Cells in October 2015, these results advance the understanding of mechanisms of toxicity of […]
